Publications & Presentations

Read our latest on-going research as we work to advance the standards of care in our therapeutic areas of focus.

Publications

A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder

Kollins SH, et al. J Child Adolesc Psychopharmacol. 2021;31(9):597-609.

View Publication

Presentations

Dose Proportionality and Effects of Food on the Pharmacokinetics of Single-Entity Serdexmethylphenidate

Braeckman R, et al. Presentation. APSARD 2022.

View Presentation

Mass Balance and Metabolic Pathway Following Oral Administration of [14C]-Serdexmethylphenidate, a Novel Prodrug of d-Methylphenidate

Braeckman R, et al. Presentation. APSARD 2022.

View Presentation

Serdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C Evaluated Over 13 Hours in a Randomized, Double-blind, Placebo-controlled Laboratory Classroom Study

Oh C, et al. Presentation. CHADD 2021.

View Presentation

Steady-State Pharmacokinetics and Relative Bioavailability of Serdexmethylphenidate/d-Methylphenidate, a Treatment for Attention Deficit Hyperactivity Disorder Containing a Novel Prodrug of d-Methylphenidate

Braeckman R, et al. Presentation. Psych Congress 2021.

View Presentation

Single-dose Pharmacokinetics of Serdexmethylphenidate/d-Methylphenidate Capsules in Children and Adolescents With ADHD and Healthy Adults: An Evaluation of Age and Body Weight

Braeckman R, et al. Presentation. AACAP 2021.

View Presentation

Serdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C and WREMB-R as Evaluated in a Randomized, Double-blind, Placebo-controlled Laboratory Classroom Study

Oh C, et al. Presentation. American Psychiatric Nurses Association 2021.

View Presentation
Back to top